| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |